EdgarLookup

MARRIOTT INTERNATIONAL INC /MD/ — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that MARRIOTT INTERNATIONAL INC /MD/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
9.9%
Profit Margin
Net income ÷ revenue
9.4%
Return on Assets
Net income ÷ assets
+4.3%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $26.19B Feb 10, 2026
FY2025 Dec 31, 2024 $25.10B Feb 10, 2026
FY2025 Dec 31, 2023 $23.71B Feb 10, 2026
FY2024 Dec 31, 2022 $20.77B Feb 11, 2025
FY2023 Dec 31, 2021 $13.86B Feb 13, 2024
FY2020 Dec 31, 2020 $2.17B Feb 18, 2021
FY2020 Sep 30, 2020 $2.25B Feb 18, 2021
FY2020 Jun 30, 2020 $1.46B Feb 18, 2021
FY2020 Mar 31, 2020 $4.68B Feb 18, 2021
FY2020 Dec 31, 2019 $5.37B Feb 18, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.60B Feb 10, 2026
FY2025 Dec 31, 2024 $2.38B Feb 10, 2026
FY2025 Dec 31, 2023 $3.08B Feb 10, 2026
FY2024 Dec 31, 2022 $2.36B Feb 11, 2025
FY2023 Dec 31, 2021 $1.10B Feb 13, 2024
FY2020 Dec 31, 2020 ($164.00M) Feb 18, 2021
FY2020 Sep 30, 2020 $100.00M Feb 18, 2021
FY2020 Jun 30, 2020 ($234.00M) Feb 18, 2021
FY2020 Mar 31, 2020 $31.00M Feb 18, 2021
FY2020 Dec 31, 2019 $279.00M Feb 18, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.14B Feb 10, 2026
FY2025 Dec 31, 2024 $3.77B Feb 10, 2026
FY2025 Dec 31, 2023 $3.86B Feb 10, 2026
FY2024 Dec 31, 2022 $3.46B Feb 11, 2025
FY2023 Dec 31, 2021 $1.75B Feb 13, 2024
FY2020 Dec 31, 2020 ($128.00M) Feb 18, 2021
FY2020 Sep 30, 2020 $252.00M Feb 18, 2021
FY2020 Jun 30, 2020 ($154.00M) Feb 18, 2021
FY2020 Mar 31, 2020 $114.00M Feb 18, 2021
FY2020 Dec 31, 2019 $274.00M Feb 18, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.21B Feb 10, 2026
FY2025 Dec 31, 2024 $2.75B Feb 10, 2026
FY2025 Dec 31, 2023 $3.17B Feb 10, 2026
FY2024 Dec 31, 2022 $2.36B Feb 11, 2025
FY2023 Dec 31, 2021 $1.18B Feb 13, 2024
FY2022 Dec 31, 2020 $1.64B Feb 14, 2023
FY2021 Dec 31, 2019 $1.69B Feb 15, 2022
FY2020 Dec 31, 2018 $2.36B Feb 18, 2021
FY2019 Dec 31, 2017 $2.23B Feb 27, 2020
FY2018 Dec 31, 2016 $1.62B Mar 1, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2024 Dec 31, 2024 $750.00M Feb 11, 2025
FY2024 Dec 31, 2023 $452.00M Feb 11, 2025
FY2024 Dec 31, 2022 $332.00M Feb 11, 2025
FY2023 Dec 31, 2021 $183.00M Feb 13, 2024
FY2022 Dec 31, 2020 $135.00M Feb 14, 2023
FY2021 Dec 31, 2019 $653.00M Feb 15, 2022
FY2020 Dec 31, 2018 $556.00M Feb 18, 2021
FY2019 Dec 31, 2017 $240.00M Feb 27, 2020
FY2018 Dec 31, 2016 $199.00M Mar 1, 2019
FY2017 Dec 31, 2015 $305.00M Feb 15, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $27.54B Feb 10, 2026
FY2025 Dec 31, 2024 $26.18B Feb 10, 2026
FY2024 Dec 31, 2023 $25.67B Feb 11, 2025
FY2023 Dec 31, 2022 $24.82B Feb 13, 2024
FY2022 Dec 31, 2021 $25.55B Feb 14, 2023
FY2021 Dec 31, 2020 $24.70B Feb 15, 2022
FY2020 Dec 31, 2019 $25.05B Feb 18, 2021
FY2019 Dec 31, 2018 $23.70B Feb 27, 2020
FY2018 Dec 31, 2017 $23.85B Mar 1, 2019
FY2017 Dec 31, 2016 $24.14B Feb 15, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($3.77B) Feb 10, 2026
FY2025 Dec 31, 2024 ($2.99B) Feb 10, 2026
FY2025 Dec 31, 2023 ($682.00M) Feb 10, 2026
FY2025 Dec 31, 2022 $568.00M Feb 10, 2026
FY2024 Dec 31, 2021 $1.41B Feb 11, 2025
FY2023 Dec 31, 2020 $430.00M Feb 13, 2024
FY2022 Dec 31, 2019 $703.00M Feb 14, 2023
FY2021 Dec 31, 2018 $2.23B Feb 15, 2022
FY2020 Dec 31, 2017 $3.58B Feb 18, 2021
FY2019 Dec 31, 2016 $5.12B Feb 27, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.91B Feb 10, 2026
FY2025 Dec 31, 2024 $8.73B Feb 10, 2026
FY2024 Dec 31, 2023 $8.89B Feb 11, 2025
FY2023 Dec 31, 2022 $8.87B Feb 13, 2024
FY2022 Dec 31, 2021 $9.07B Feb 14, 2023
FY2021 Dec 31, 2020 $9.18B Feb 15, 2022
FY2020 Dec 31, 2019 $9.05B Feb 18, 2021
FY2019 Dec 31, 2018 $9.04B Feb 27, 2020
FY2018 Dec 31, 2017 $9.21B Mar 1, 2019
FY2017 Dec 31, 2016 $7.60B Feb 15, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $18.41B Feb 10, 2026
FY2025 Dec 31, 2024 $16.53B Feb 10, 2026
FY2024 Dec 31, 2023 $14.84B Feb 11, 2025
FY2023 Dec 31, 2022 $12.34B Feb 13, 2024
FY2022 Dec 31, 2021 $10.31B Feb 14, 2023
FY2021 Dec 31, 2020 $9.21B Feb 15, 2022
FY2020 Dec 31, 2019 $9.64B Feb 18, 2021
FY2019 Dec 31, 2018 $8.98B Feb 27, 2020
FY2018 Dec 31, 2017 $7.24B Mar 1, 2019
FY2017 Dec 31, 2016 $6.50B Feb 15, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $358.00M Feb 10, 2026
FY2025 Dec 31, 2024 $396.00M Feb 10, 2026
FY2024 Dec 31, 2023 $338.00M Feb 11, 2025
FY2023 Dec 31, 2022 $507.00M Feb 13, 2024
FY2022 Dec 31, 2021 $1.39B Feb 14, 2023
FY2021 Dec 31, 2020 $877.00M Feb 15, 2022
FY2020 Dec 31, 2019 $225.00M Feb 18, 2021
FY2019 Dec 31, 2018 $316.00M Feb 27, 2020
FY2018 Dec 31, 2017 $383.00M Mar 1, 2019
FY2017 Dec 31, 2016 $858.00M Feb 15, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $23.00M Feb 10, 2026
FY2025 Dec 31, 2024 $55.00M Feb 10, 2026
FY2024 Dec 31, 2023 $56.00M Feb 11, 2025
FY2023 Dec 31, 2022 $92.00M Feb 13, 2024
FY2022 Dec 31, 2021 $135.00M Feb 14, 2023
FY2021 Dec 31, 2020 $143.00M Feb 15, 2022
FY2020 Dec 31, 2019 $247.00M Feb 18, 2021
FY2011 Dec 30, 2011 $2.17B Feb 16, 2012
FY2010 Dec 31, 2010 $2.83B Feb 18, 2011

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 9 Feb 10, 2026
FY2025 Dec 31, 2024 8 Feb 10, 2026
FY2025 Dec 31, 2023 10 Feb 10, 2026
FY2024 Dec 31, 2022 7 Feb 11, 2025
FY2023 Dec 31, 2021 3 Feb 13, 2024
FY2020 Dec 31, 2020 0 Feb 18, 2021
FY2020 Sep 30, 2020 0 Feb 18, 2021
FY2020 Jun 30, 2020 0 Feb 18, 2021
FY2020 Mar 31, 2020 0 Feb 18, 2021
FY2020 Dec 31, 2019 0 Feb 18, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 9 Feb 10, 2026
FY2025 Dec 31, 2024 8 Feb 10, 2026
FY2025 Dec 31, 2023 10 Feb 10, 2026
FY2024 Dec 31, 2022 7 Feb 11, 2025
FY2023 Dec 31, 2021 3 Feb 13, 2024
FY2020 Dec 31, 2020 0 Feb 18, 2021
FY2020 Sep 30, 2020 0 Feb 18, 2021
FY2020 Jun 30, 2020 0 Feb 18, 2021
FY2020 Mar 31, 2020 0 Feb 18, 2021
FY2020 Dec 31, 2019 0 Feb 18, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 265.86M Feb 10, 2026
FY2024 Dec 31, 2024 276.67M Feb 11, 2025
FY2023 Dec 31, 2023 290.54M Feb 13, 2024
FY2022 Dec 31, 2022 310.60M Feb 14, 2023
FY2021 Dec 31, 2021 326.30M Feb 15, 2022
FY2020 Dec 31, 2020 324.40M Feb 18, 2021
FY2019 Dec 31, 2019 324.00M Feb 27, 2020
FY2018 Dec 31, 2018 339.10M Mar 1, 2019
FY2017 Dec 31, 2017 359.10M Feb 15, 2018
FY2016 Dec 31, 2016 386.10M Feb 21, 2017

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $718.00M Feb 10, 2026
FY2025 Dec 31, 2024 $682.00M Feb 10, 2026
FY2025 Dec 31, 2023 $587.00M Feb 10, 2026
FY2024 Dec 31, 2022 $321.00M Feb 11, 2025
FY2023 Dec 31, 2021 $0 Feb 13, 2024
FY2022 Dec 31, 2020 $156.00M Feb 14, 2023
FY2021 Dec 31, 2019 $612.00M Feb 15, 2022
FY2020 Dec 31, 2018 $543.00M Feb 18, 2021
FY2019 Dec 31, 2017 $482.00M Feb 27, 2020
FY2018 Dec 31, 2016 $374.00M Mar 1, 2019